WT1 and acute myeloid leukemia: While several studies suggest the potential role of WT1 in MRD assessment during chemotherapy and allo-SCT, the WT1 MRD assay has not garnered sufficient attention and is not commonly utilized in AML due to the absence of large-scale, controlled studies [12].